Your session is about to expire
← Back to Search
iCanChange E-Intervention for Cannabis Use Disorder (iCC Trial)
iCC Trial Summary
This trial will test the feasibility of a mobile health e-intervention for young people with psychosis who use cannabis. The goal is to help them set realistic goals for reducing their cannabis use.
iCC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowiCC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.iCC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can understand French or English.I have been diagnosed with a psychotic disorder.I have been attending an early psychosis clinic for at least 3 months.I am between 18 and 35 years old.
- Group 1: Experimental: CHAMPS and mEIS
- Group 2: No Intervention: EIS alone
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this investigation open to new participants?
"The current data on clinicaltrials.gov indicates that this particular medical trial is not currently enrolling patients. It was first uploaded to the database on March 31st 2022 and has maintained its status since then, but there are still 118 other trials actively looking for participants at present."
What goals is this research endeavor attempting to accomplish?
"The primary outcome of this experiment, assessed over 12 weeks, is retention rates. Secondary objectives comprise cannabis use (quantity and frequency captured via the Timeline Follow Back tool), participant satisfaction (measured by a modified version of the CSQ-8 questionnaire) and acceptability (number of iCC modules completed)."
Are participants aged 55 or over being accepted in this experiment?
"This medical trial seeks patients aged 18-35 to enroll in the study. Furthermore, there are 15 studies available for minors and 48 trials open to individuals 65 years of age or older."
What is the geographic breadth of this research project?
"Across Canada, 5 sites are actively recruiting patients for this medical trial. Locations include Nova Scotia Early Psychosis Program in Halifax, Clinic Connec-T - Institut universitaire en santé mentale de Montréal in Montreal, and Clinique JAP, Centre hospitalier de l'Université de Montréal in Quebec City as well as other locations throughout the country."
Is it possible for me to partake in this experiment?
"This research effort focuses on individuals aged 18 to 35 with a cannabis use disorder, and approximately 100 participants are needed."
Share this study with friends
Copy Link
Messenger